483 Woodfield Pharmaceutical Oct 2018

483 Woodfield Pharmaceutical Oct 2018

Stephen Brown FDA$119.00 - Available Now

FDA investigators audited the Woodfield Pharmaceutical - Houston, TX, United States facility and issued inspectional observations (via FDA 483) on 03 Oct 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 03 Oct 2018
  • Location: Houston, United States
  • FEI: 1628196
Add To Cart